1-248295193-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004692.2(OR2T12):c.386G>A(p.Arg129Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000994 in 1,609,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004692.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2T12 | NM_001004692.2 | c.386G>A | p.Arg129Gln | missense_variant | 3/3 | ENST00000641276.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2T12 | ENST00000641276.1 | c.386G>A | p.Arg129Gln | missense_variant | 3/3 | NM_001004692.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000534 AC: 8AN: 149836Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.00000880 AC: 2AN: 227212Hom.: 0 AF XY: 0.00000811 AC XY: 1AN XY: 123366
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1459422Hom.: 0 Cov.: 76 AF XY: 0.00000138 AC XY: 1AN XY: 726016
GnomAD4 genome AF: 0.0000534 AC: 8AN: 149836Hom.: 0 Cov.: 26 AF XY: 0.0000411 AC XY: 3AN XY: 73002
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.386G>A (p.R129Q) alteration is located in exon 1 (coding exon 1) of the OR2T12 gene. This alteration results from a G to A substitution at nucleotide position 386, causing the arginine (R) at amino acid position 129 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at